Hookipa Historical Cash Flow
| HOOK Stock | USD 2.58 0.06 2.38% |
Analysis of Hookipa Pharma cash flow over time is an excellent tool to project Hookipa Pharma future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 2.2 M or Change In Working Capital of 3.4 M as it is a great indicator of Hookipa Pharma ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Hookipa Pharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Hookipa Pharma is a good buy for the upcoming year.
Hookipa |
About Hookipa Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Hookipa balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Hookipa's non-liquid assets can be easily converted into cash.
Hookipa Pharma Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Hookipa Pharma to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Hookipa Pharma operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Hookipa Pharma's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Hookipa Pharma current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.At this time, Hookipa Pharma's Change To Liabilities is quite stable compared to the past year. Issuance Of Capital Stock is expected to rise to about 57.8 M this year, although the value of Change In Cash will most likely fall to about 3.9 M.
Hookipa Pharma cash flow statement Correlations
Click cells to compare fundamentals
Hookipa Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hookipa Pharma cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 112.0M | 75.1M | 203K | 75.3M | 86.6M | 60.2M | |
| Investments | (2.0M) | (2.4M) | (12.6M) | (5.0M) | (4.3M) | (4.6M) | |
| Change In Cash | 65.0M | 29.6M | (76.3M) | 46.5M | 4.1M | 3.9M | |
| Net Borrowings | (2.3M) | (1.4M) | (438K) | (3.0M) | (2.7M) | (2.6M) | |
| Stock Based Compensation | 5.6M | 8.7M | 7.6M | 5.0M | 2.3M | 2.2M | |
| Free Cash Flow | (43.7M) | (41.7M) | (78.6M) | (25.0M) | (61.7M) | (64.8M) | |
| Change In Working Capital | (7.4M) | (8.1M) | (3.9M) | 36.1M | 5.3M | 3.4M | |
| Begin Period Cash Flow | 48.6M | 113.6M | 143.2M | 66.9M | 113.4M | 88.0M | |
| Total Cashflows From Investing Activities | (2.0M) | (2.4M) | (12.6M) | (5.0M) | (4.5M) | (4.7M) | |
| Other Cashflows From Financing Activities | 37.3M | 32.2M | (12.6M) | 29.4M | 18.4M | 19.5M | |
| Depreciation | 1.4M | 4.2M | 4.6M | 3.6M | 3.6M | 2.9M | |
| Other Non Cash Items | 1.7M | 53K | 1.2M | 160K | 12.8M | 13.5M | |
| Capital Expenditures | 2.0M | 2.4M | 12.6M | 5.0M | 4.2M | 4.6M | |
| Total Cash From Operating Activities | (41.7M) | (39.3M) | (66.0M) | (20.0M) | (57.5M) | (54.6M) | |
| Change To Account Receivables | (3.6M) | (3.6M) | (1.9M) | (341K) | 3.5M | 3.6M | |
| Change To Operating Activities | (3.5M) | (11.4M) | (4.2M) | 2.9M | 3.4M | 3.6M | |
| Net Income | (43.0M) | (44.1M) | (75.7M) | (64.9M) | (81.6M) | (77.5M) | |
| Total Cash From Financing Activities | 109.8M | 73.4M | (235K) | 72.3M | 65.7M | 60.8M | |
| End Period Cash Flow | 113.6M | 143.2M | 66.9M | 113.4M | 117.5M | 104.4M | |
| Change To Netincome | 5.3M | 8.3M | 8.9M | 5.2M | 6.0M | 5.4M | |
| Change To Liabilities | (239K) | 6.8M | 5.2M | 2.1M | 2.4M | 4.5M | |
| Issuance Of Capital Stock | 112.0M | 75.1M | 203K | 75.3M | 46.3M | 57.8M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.67) | Revenue Per Share 4.403 | Quarterly Revenue Growth (0.52) | Return On Assets (0.20) | Return On Equity (0.49) |
The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.